跳至主要内容
临床试验/NCT00732849
NCT00732849已完成4 期

The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery - A Prospective, Randomized, Clinical Trial.

Jagiellonian University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2002年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
600
试验地点
1
主要终点
Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients

研究概览

简要总结

The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery

详细描述

All patients qualified between June 2002 and December 2007 to total and distal subtotal gastrectomy or pancreaticoduodenectomy were screened for eligibility to participate in the study. Malnutrition was defined by the Nutritional Risk Index (NRI), calculated according to the formula used in the Veterans Administration Cooperative Group trial.{, 1991 #70} Additional eligibility criteria included: age between 18 and 80 years, Karnofsky performance status score of 80 or more, and adequate organ function measured by routine blood tests. Patients without features of malnutrition, as well as those with disseminated tumors, serious comorbidities (American Society of Anesthesiologists risk class of 4 or 5), and renal or liver failure were excluded. The study was designed to test the hypothesis that immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients following elective upper GI surgery. Therefore, patients were randomly assigned in a 2×2 factorial design to four groups receiving immunostimulating versus normal diets, and enteral versus intravenous nutritional support. The secondary objective of the study was to evaluate the effect of nutritional intervention on overall morbidity and mortality rates, and the length of hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • age between 18 and 80 years,
  • Karnofsky performance status score of 80 or more,
  • adequate organ function measured by routine blood tests

排除标准

  • patients <18 or > 80
  • Karnofsky performance < 50

研究组 & 干预措施

4

Experimental

Immunomodulating Parenteral Nutrition: Aminomel, Lipofundin, Glucose, Cernevit, Tracutil, electrolytes + Omegaven (Fresenius Kabi), Dipepitven (Fresenius Kabi)

干预措施: Reconvan, Dipeptiven, Omegaven (Drug)

1

No Intervention

Standard Enteral Nutrition - Peptisorb, Nutricia Ltd.

干预措施: Reconvan, Dipeptiven, Omegaven (Drug)

2

No Intervention

Standard Parenteral Nutrition: Aminomel, Lipofundin, Glucose, Cernevit, Tracutil, electrolytes

干预措施: Reconvan, Dipeptiven, Omegaven (Drug)

3

Experimental

Immunomodulating Enteral Nutrition: Reconvan, Fresenius Kabi Poland

干预措施: Reconvan, Dipeptiven, Omegaven (Drug)

结局指标

主要结局

Immunonutrition and enteral nutrition would reduce the incidence of infectious complications in a population of malnourished patients

时间窗: Immunonutrition

次要结局

  • To evaluate the effect of nutritional intervention on overall morbidity and mortality rates, and the length of hospital stay(morbidity)

研究者

发起方
Jagiellonian University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

The Impact of the Type and Route of Nutritional... | 临床试验